Clinical trials
Phase 2 Venous Thromboembolism trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 5 |
| Regeneron Pharmaceuticals | 2 |
| GlaxoSmithKline | 1 |
| Ribocure Pharmaceuticals AB | 1 |
| Sanofi | 1 |
| Tetherex Pharmaceuticals Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Venous Thromboembolism | 11 |
| Venous Thrombosis | 5 |
| Pulmonary Embolism | 2 |
| Atrial Fibrillation | 1 |
| Disease | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.